XML 23 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities:    
Net loss $ (4,151,079) $ (6,027,900)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 112,637 166,161
Noncash lease expense 123,505 94,544
Stock option expense 82,626 2,059,634
Issuance of common stock for services 57,120
Restricted stock compensation 114,779 9,590
Bad debt expense 67,003
Loss on disposition of asset 41,108 12,618
Loss from investment in unconsolidated affiliate 3,497 2,296
Change in operating assets and liabilities:    
Accounts receivable (143,313) (91,648)
Inventories (281,908) (48,156)
Prepaid expenses and other current assets 246,393 (432,286)
Other assets (9,261) (25,527)
Accounts payable 96,494 398,464
Deferred income 2,570 113,209
Lease liability – operating lease (136,330) (91,525)
Accrued expenses and other current liabilities 109,138 (305,129)
Other non-current liabilities 14,646 11,627
Net cash used in operating activities (3,650,375) (4,154,028)
Investing activities:    
Purchase of equipment (16,514) (165,689)
Acquisition of Dripkit (373,832)
Net cash used in investing activities (16,514) (539,521)
Financing activities:    
Proceeds from issuance of common stock, exercise of options 12,600
Repayment of loans (3,939) (28,047)
Repayment of finance lease (17,616) (11,870)
Proceeds from issuance of common stock, ATM offering 88,426
Proceeds from issuance of common stock, exercise of warrants, net of issuance costs 1,702,596
Advances received of sale of equity securities 300,000
Net cash provided by (used in) financing activities (21,555) 2,063,705
Effect of foreign exchange on cash 72,618 25,593
Net change in cash (3,615,826) (2,604,251)
Cash, beginning of period 8,315,053 10,815,954
Cash, end of period 4,699,227 8,211,703
Supplemental disclosure of cash flow information:    
Cash paid for interest 2,034 5,390
Non-cash transactions:    
ROU assets and liabilities added during the period 558,371
Common stock issued in acquisition of Dripkit   386,844
Forgiveness of stock issuance costs 25,000
Stock issuance costs accrued $ 97,867